Bloomberg Businessweek cover image

Trump Plans His Tariff ‘Liberation Day’ With More Targeted Push

Bloomberg Businessweek

CHAPTER

Navigating the Weight Loss Drug Landscape

This chapter explores the evolving market for weight loss medications, focusing on key players like Novo Nordisk and Eli Lilly. It discusses the implications of GLP-1 drugs for obesity and diabetes management, the importance of a holistic approach to treatment, and the risks associated with unsupervised medication use. Additionally, it examines the multifaceted nature of obesity, emphasizing that effective management requires more than just dietary changes.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner